New investigations into retatrutide, a dual activator for GLP-1 and GIP receptors, are showing promising results in managing obesity and related 2 condition. Preclinical data suggest a distinct process contributing to https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/